The Trump administration has announced it will terminate $45 million in annual financial support for Namibia’s HIV response program after roughly twenty years of consistent payments.
The final $45 million payment is scheduled for fiscal year 2027, after which the arrangement will shift to what officials are describing as a technical cooperation model going forward.
A joint statement released Friday from Namibia’s Ministry of International Relations and Trade and the U.S. Embassy in Namibia outlined the terms of the transition and the rationale behind the change.
U.S. Ambassador to Namibia John Giordano offered a positive framing of the development, stating in the joint release that “this transition is a celebration of Namibia’s leadership and a model for what is possible.”
Under the previous arrangement, U.S. backing supported investments in HIV testing, counselling, community-based organizations, and other key health system interventions across the country.
Going forward, Namibia will be expected to integrate its HIV response into a sustainable national health system guided by the country’s own priorities, policies, and legal frameworks.
The shift is part of a broader strategy the Trump administration has called the “America First Global Health Strategy,” which calls for a significant reduction in U.S. funding for foreign health programs.
That strategy explicitly criticized existing global health programs as “inefficient and wasteful” and argued they had “created a culture of dependency among recipient countries.”
The Namibia decision is consistent with a string of moves the administration has made in the global health space, including freezing and ultimately canceling a range of global HIV projects.
The administration also moved to eliminate the U.S. Agency for International Development and canceled U.S. support to UNAIDS in 2025, signaling a sweeping retreat from Washington’s long-standing commitments to international health programs.
Critics of the administration’s global health cuts have raised concerns that nations heavily reliant on U.S. HIV funding may struggle to absorb the financial gap left behind.
Namibia’s ability to sustain its HIV programs independently will likely be closely watched by global health advocates as a test case for similar transitions in other recipient countries.
